Page last updated: 2024-08-24

gemcitabine and Arrhythmias, Cardiac

gemcitabine has been researched along with Arrhythmias, Cardiac in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's0 (0.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Kume, S; Kurokawa, T; Liu, G; Liu, Y; Morishima, M; Ono, K; Osanai, H; Wang, P; Wei, M; Yoshimura, K; Zheng, M; Zhu, X1
Lénárt, T; Sárosi, V1
Alloisio, A; Bruzzi, P; Costa, R; Maineri, P; Ratto, GB; Vassallo, G1
Kocijancic, I; Kovac, V; Segedin, B; Smrdel, U; Vrankar, M; Zwitter, M1
Asadpour, B; Buell, U; Coenen, HH; Demirel, C; Eble, MJ; Gagel, B; Hamacher, K; Kaiser, HJ; Pinkawa, M; Piroth, M; Reinartz, P; Stanzel, S; Zimny, M1

Reviews

1 review(s) available for gemcitabine and Arrhythmias, Cardiac

ArticleYear
Twelve-year experience with left atrial resection in the treatment of non-small cell lung cancer.
    The Annals of thoracic surgery, 2004, Volume: 78, Issue:1

    Topics: Aged; Arrhythmias, Cardiac; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Deoxycytidine; Follow-Up Studies; Gemcitabine; Heart Atria; Humans; Life Tables; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Postoperative Complications; Radiotherapy, Adjuvant; Retrospective Studies; Survival Analysis; Treatment Outcome

2004

Trials

2 trial(s) available for gemcitabine and Arrhythmias, Cardiac

ArticleYear
Phase I-II trial of low-dose gemcitabine in prolonged infusion and cisplatin for advanced non-small cell lung cancer.
    Anti-cancer drugs, 2005, Volume: 16, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Female; Gemcitabine; Heart Ventricles; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Thrombocytosis

2005
[18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility study.
    BMC cancer, 2006, Mar-04, Volume: 6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Combined Modality Therapy; Deoxycytidine; Feasibility Studies; Female; Fluorodeoxyglucose F18; Gemcitabine; Glucose; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Misonidazole; Positron-Emission Tomography; Prospective Studies; Pulmonary Embolism; Radiopharmaceuticals; Treatment Outcome; Vinblastine; Vinorelbine

2006

Other Studies

2 other study(ies) available for gemcitabine and Arrhythmias, Cardiac

ArticleYear
Electrophysiological evaluation of an anticancer drug gemcitabine on cardiotoxicity revealing down-regulation and modification of the activation gating properties in the human rapid delayed rectifier potassium channel.
    PloS one, 2023, Volume: 18, Issue:2

    Topics: Animals; Antineoplastic Agents; Arrhythmias, Cardiac; Carcinoma, Non-Small-Cell Lung; Cardiotoxicity; Delayed Rectifier Potassium Channels; Down-Regulation; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Gemcitabine; HEK293 Cells; Humans; Lung Neoplasms; Rats

2023
[Gemcitabine-cisplatin combination in the first line treatment of non-small cell lung cancer. Our experience and analysis of safety].
    Magyar onkologia, 2003, Volume: 47, Issue:2

    Topics: Adult; Aged; Albumins; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Carcinoma, Non-Small-Cell Lung; Cisplatin; Constipation; Creatinine; Deoxycytidine; Diarrhea; Drug Administration Schedule; Drug Eruptions; Dyspnea; Female; Gemcitabine; Hemoglobins; Humans; Hyponatremia; Lung Neoplasms; Male; Middle Aged; Neutropenia; Retrospective Studies; Severity of Illness Index; Taste Disorders; Thrombocytopenia; Treatment Outcome

2003